These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26172319)

  • 1. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
    El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
    Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.
    Chung EK; Chen LW; Chan YS; Yung KK
    J Comp Neurol; 2008 Dec; 511(4):421-37. PubMed ID: 18831527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Meng T; Yuan S; Zheng Z; Liu T; Lin L
    Neuroscience; 2015 Feb; 286():308-15. PubMed ID: 25499317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations.
    Touchon JC; Moore C; Frederickson J; Meshul CK
    Synapse; 2004 Mar; 51(4):287-98. PubMed ID: 14696016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease.
    Solis O; Limón DI; Flores-Hernández J; Flores G
    Synapse; 2007 Jun; 61(6):450-8. PubMed ID: 17372982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
    Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats.
    Jia YJ; Deng JH; Zhang WZ; Sun ZL; Yang J; Yu Y; Gong XL; Jia J; Wang XM
    CNS Neurosci Ther; 2017 Jan; 23(1):23-32. PubMed ID: 27412260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Wang S; Hu LF; Zhang Y; Sun T; Sun YH; Liu SY; Ding JH; Wu J; Hu G
    Neuropsychopharmacology; 2006 May; 31(5):933-40. PubMed ID: 16123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
    Meshul CK; Allen C
    Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
    He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
    Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response.
    Mendes-Pinheiro B; Soares-Cunha C; Marote A; Loureiro-Campos E; Campos J; Barata-Antunes S; Monteiro-Fernandes D; Santos D; Duarte-Silva S; Pinto L; José Salgado A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences.
    Mourre C; Manrique C; Camon J; Aidi-Knani S; Deltheil T; Turle-Lorenzo N; Guiraudie-Capraz G; Amalric M
    Neuropharmacology; 2017 Feb; 113(Pt A):519-532. PubMed ID: 27825825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
    Brown AR; Hu B; Antle MC; Teskey GC
    Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of astroglial glutamate transporter GLT-1 in the lateral habenula is associated with depressive-like behaviors in a rat model of Parkinson's disease.
    Lyu S; Guo Y; Zhang L; Tang G; Li R; Yang J; Gao S; Li W; Liu J
    Neuropharmacology; 2021 Sep; 196():108691. PubMed ID: 34197892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model.
    Wang Y; Wang Y; Liu J; Wang X
    Neurosci Bull; 2018 Jun; 34(3):476-484. PubMed ID: 29508251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.